News & Investors

ADR program

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

ADR

American Depositary Receipt

Epigenomics has established a Level 1 American Depositary Receipt (ADR) program in the U.S.A. ADRs of Epigenomics are US dollar denominated certificates representing ordinary shares of the Company at a ratio of five ordinary shares to one Epigenomics ADR. Epigenomics ADRs can be traded on the US OTCQX International effective as of January 10, 2014 under the ticker symbol EPGNY.

 

Type of Program Sponsored Level 1 ADR Program
Ratio 1 ADR = 5 ordinary shares
Ticker Symbol EPGNY
CUSIP 29428N102
DR ISIN US29428N1028
Country Germany
Underlying SEDOL B5SL043
Underlying ISIN DE000A11QW50
Depositary Bank of New York Mellon

 

 

About Level 1 American Depositary Receipt (ADR) Program

The Level 1 ADR program allows US investors to trade shares in the form of securities from companies that are not listed in the US. ADRs represent ordinary shares of a company at a certain ratio. They are traded on the US over-the-counter (OTC) market and are issued according to the demand (Unsponsored) or in cooperation with one designated depositary bank that acts as the transfer agent (Sponsored). The price generally tracks the price of the foreign security in its home market, adjusted for the ratio of ADRs to foreign company shares.

For questions about creating Epigenomics ADRs, please contact BNY Mellon:

New York
Ravi Davis
email: ravi.davis@bnymellon.com
Tel: +1 212 815 4245
London
Mark Lewis
email: mark.lewis@bnymellon.com
Tel: +44 (0)20 7964 6089